Aminobenzazepine compounds, immunoconjugates, and uses thereof
AssigneeBolt Biotherapeutics, Inc.
InventorsShelley Erin Ackerman, Michael N. Alonso, Romas Kudirka, Arthur Lee, Brian Safina, Matthew Zhou
Life of this patent
Estimating the term…
Loading patent…
AssigneeBolt Biotherapeutics, Inc.
InventorsShelley Erin Ackerman, Michael N. Alonso, Romas Kudirka, Arthur Lee, Brian Safina, Matthew Zhou
Estimating the term…
The invention provides immunoconjugates of Formula I or III comprising an antibody linked by conjugation to one or more aminobenzazepine derivatives. The invention also provides aminobenzazepine derivative intermediate compositions of Formula II comprising a reactive functional group. Such intermediate compositions are suitable substrates for formation of the immunoconjugates through a linker or linking moiety. The invention further provides methods of treating cancer with the immunoconjugates.
An immunoconjugate comprising an antibody covalently attached to one or more aminobenzazepine moieties by a linker, and having Formula I:
The immunoconjugate of claim 11 wherein AA1 and AA2 are independently selected from H, —CH3, —CH(CH3)2, —CH2(C6H5), —CH2CH2CH2CH2NH2, —CH2CH2CH2NHC(NH)NH2, —CH2CH(CH3)2, —CH2SO3H, and —CH2CH2CH2NHC(O)NH2.
An aminobenzazepine-linker compound of Formula II:
Dependencies are inferred from the claim text.